🇰🇪 Kenya Prévalence de la mutilation génitale féminine
Kenya Prévalence de la mutilation génitale féminine was 14.80 in 2022, down 29.5% from 2014, according to World Bank data. The 10-year average is 26.54. Historical data available from 1998 to 2022 (5 data points). The all-time high was 37.60 in 1998.
Source: World Bank World Development Indicators • 1998–2022 • 5 data points • Health
Latest Value
14.80
2022
Year-on-Year
-29.5%
vs 2014
10-Year Average
26.54
2013–2022
Range
High: 37.60 (1998)
Low: 14.80 (2022)
Kenya Prévalence de la mutilation génitale féminine (%) — 1998 to 2022
Loading chart...
About this Indicator
Percentage of women aged 15–49 who have gone through partial or total removal of the female external genitalia or other injury to the female genital organs for cultural or other non-therapeutic reasons.
Historical Data Table
| Year | Value |
|---|---|
| 2022 | 14.80 |
| 2014 | 21.00 |
| 2009 | 27.10 |
| 2003 | 32.20 |
| 1998 | 37.60 |
Embed this chart
Copy and paste this code to embed the chart on your website:
<iframe src="https://nationstat.com/fr/country/kenya/female-genital-mutilation-prevalence" width="800" height="500" frameborder="0"></iframe>Compare with Other Countries
🇧🇯Bénin
9.202014
🇧🇫Burkina Faso
56.102021
🇨🇫République centrafricaine
21.602019
🇨🇮Côte d'Ivoire
36.702016
🇨🇲Cameroun
1.402004
🇩🇯Djibouti
90.102019
🇪🇬Égypte
87.202015
🇪🇷Érythrée
83.002010
🇪🇹Éthiopie
65.202016
🇬🇭Ghana
2.402018
🇬🇳Guinée
94.502018
🇬🇲Gambie
72.602020
🇬🇼Guinée-Bissau
52.102019
🇮🇶Irak
7.402018
🇰🇪Kenya
14.802022
🇱🇷Liberia
31.802020
🇲🇻Maldives
12.902017
🇲🇱Mali
88.602018
🇲🇷Mauritanie
63.902021
🇳🇪Niger
2.002012
🇳🇬Nigeria
15.102021
🇸🇩Soudan
86.602014
🇸🇳Sénégal
20.102023
🇸🇱Sierra Leone
83.002019
🇸🇴Somalie
99.202020
🇹🇩Tchad
34.102019
🇹🇬Togo
3.102017
🇹🇿Tanzanie
8.202022
🇺🇬Ouganda
0.302016
🇾🇪Yémen
18.502013
Related Indicators
Adultes (15+ ans) et enfants (0-14) récemment infectés par le VIH
20.0K
2024
Adultes (15-49 ans) récemment infectés par le VIH
15.0K
2024
Couverture de la thérapie antirétrovirale pour PTME (% femmes enceintes vivant avec le VIH)
90.0
2024
Couverture de la thérapie antirétrovirale (% personnes vivant avec le VIH)
87.0
2024
Coefficient de dépendance démographique (% de la population en âge de travailler)
66.1
2024